Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Invega Sustenna

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    I3 Pharms’ Generics Paliperidone Receives Approval in US
    I3 Pharms’ Generics Paliperidone Receives Approval in US

    07 May 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205402

    FDA
    07 May 2026
    Share Share
    Apotex’s Generics Paliperidone Receives Approval in US
    Apotex’s Generics Paliperidone Receives Approval in US

    26 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203279

    FDA
    26 Jan 2026
    Share Share
    Eskayef`s Generics Paliperidone Receives Approval in US
    Eskayef`s Generics Paliperidone Receives Approval in US

    04 Sep 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218755

    FDA
    04 Sep 2025
    Share Share
    J&J Defeats Generic Drugmakers in Appeal Over Schizophrenia Drug
    J&J Defeats Generic Drugmakers in Appeal Over Schizophrenia Drug

    09 Jul 2025

    // REUTERS

    https://www.reuters.com/legal/litigation/jj-defeats-generic-drugmakers-us-appeal-over-schizophrenia-treatment-2025-07-08/

    REUTERS
    09 Jul 2025
    Share Share
    Sumitomo to market Johnson & Johnson's schizophrenia drug in Japan
    Sumitomo to market Johnson & Johnson's schizophrenia drug in Japan

    21 Jan 2025

    // BIOSPECTRUM

    https://www.biospectrumasia.com/news/25/25470/sumitomo-to-market-johnson-johnsons-schizophrenia-drug-in-japan.html

    BIOSPECTRUM
    21 Jan 2025
    Share Share
    Zydus Pharma`s Generics Paliperidone Receives Approval in US
    Zydus Pharma`s Generics Paliperidone Receives Approval in US

    08 Oct 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217445

    FDA
    08 Oct 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.